UK Imaging Services Market Size, Share & Trends Analysis Report By Modality (X-ray Scans, CT Scans, MRI Scans, Ultrasound, Nuclear Medicine Scans), By End Use (Hospitals, Diagnostic Imaging Centers), By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
UK Imaging Services Market Growth & Trends
The UK imaging services market size is estimated treach USD 23.84 billion in 2030 and is expected tgrow at a CAGR of 7.52% from 2025 t2030. Medical imaging technologies are highly useful in detecting changes in the appearance of organs, tissues, and arteries, as well as diagnosing various diseases like cancer. Each modality has its own set of advantages for effectively identifying a variety of medical conditions. The prevalence of various disorders is predicted tincrease market growth.
Emerging innovations in medical imaging technology and their adoption by service providers are expanding the market size. For instance, in May 2020, Alliance Medical and Expandable Healthcare announced the launch of Mobile Medical Plus in the UK, a mobile imaging unit with an in-patient facility. Furthermore, the market is likely tgrow over the forecast period due tthe increased prevalence of chronic diseases such as cancer and cardiovascular disorders, which necessitates the use of advanced medical imaging technologies for diagnosis. As per the International Agency for Research on Cancer, about 457,960 new cancer cases were diagnosed in the UK in 2020, with 179,648 fatalities in the same year.
With the adoption of modern imaging technology, the number of imaging service providers in the UK is rapidly increasing. According tthe Organization for Economic Co-operation and Development (OECD), hospitals had around 7.8 MRI units and 9 CT units installed per 1,000,000 population in 2020. Furthermore, the rising frequency of CT scans in the UK is predicted tboost the overall market growth. According tthe same source, CT scans were performed in UK hospitals at a rate of 103 per 1,000 people in 2019. The low cost of CT scans compared tMRI scans is alsexpected tincrease their uptake.
In order tgrow their services and presence, the market's leading competitors are undertaking various efforts such as acquisitions and funding of medium and small-sized organizations. For instance, in March 2021, Fortius Clinic, UK's single largest orthopedic group with an international reputation in orthopedics and MSK, was acquired by Affidea Group, the leading European provider of diagnostic imaging, outpatient, and cancer care services. In July 2020, Rutherford Health entered inta partnership with Somerset NHS Foundation Trust, tprovide diagnostic services through a new diagnostics facility in Somerset, England. The diagnostics facility is expected toffer a variety of diagnostic services and assist in the delivery of test results.
UK Imaging Services Market Report Highlights
UK Imaging Services Market Growth & Trends
The UK imaging services market size is estimated treach USD 23.84 billion in 2030 and is expected tgrow at a CAGR of 7.52% from 2025 t2030. Medical imaging technologies are highly useful in detecting changes in the appearance of organs, tissues, and arteries, as well as diagnosing various diseases like cancer. Each modality has its own set of advantages for effectively identifying a variety of medical conditions. The prevalence of various disorders is predicted tincrease market growth.
Emerging innovations in medical imaging technology and their adoption by service providers are expanding the market size. For instance, in May 2020, Alliance Medical and Expandable Healthcare announced the launch of Mobile Medical Plus in the UK, a mobile imaging unit with an in-patient facility. Furthermore, the market is likely tgrow over the forecast period due tthe increased prevalence of chronic diseases such as cancer and cardiovascular disorders, which necessitates the use of advanced medical imaging technologies for diagnosis. As per the International Agency for Research on Cancer, about 457,960 new cancer cases were diagnosed in the UK in 2020, with 179,648 fatalities in the same year.
With the adoption of modern imaging technology, the number of imaging service providers in the UK is rapidly increasing. According tthe Organization for Economic Co-operation and Development (OECD), hospitals had around 7.8 MRI units and 9 CT units installed per 1,000,000 population in 2020. Furthermore, the rising frequency of CT scans in the UK is predicted tboost the overall market growth. According tthe same source, CT scans were performed in UK hospitals at a rate of 103 per 1,000 people in 2019. The low cost of CT scans compared tMRI scans is alsexpected tincrease their uptake.
In order tgrow their services and presence, the market's leading competitors are undertaking various efforts such as acquisitions and funding of medium and small-sized organizations. For instance, in March 2021, Fortius Clinic, UK's single largest orthopedic group with an international reputation in orthopedics and MSK, was acquired by Affidea Group, the leading European provider of diagnostic imaging, outpatient, and cancer care services. In July 2020, Rutherford Health entered inta partnership with Somerset NHS Foundation Trust, tprovide diagnostic services through a new diagnostics facility in Somerset, England. The diagnostics facility is expected toffer a variety of diagnostic services and assist in the delivery of test results.
UK Imaging Services Market Report Highlights
- By modality, the mri scans segment held the largest market share of about 32.8% in 2024, owing tits effective diagnostic results.
- The CT scans segment is projected texperience the fastest growth in the imaging services market during the upcoming forecast period
- Based on end-use, the hospitals segment dominated the market with a share of nearly 48% in 2024, owing tthe adoption of advanced imaging modalities by hospitals.
- The diagnostic imaging centers segment is anticipated texperience the fastest growth over the forecast period
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End use outlook
2.3. Competitive Insights
CHAPTER 3. UK IMAGING SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Growing awareness of medical imaging
3.4.2. Market restraint analysis
3.4.2.1. High radiation exposure
3.4.2.2. Lack of resources
3.5. UK Imaging Services Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
CHAPTER 4. UK IMAGING SERVICES MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global UK Imaging Services Modality Market Movement Analysis
4.3. Global UK Imaging Services Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. X-rays scans
4.4.1. X-rays scans market estimates and forecast 2018 to 2030 (USD Million)
4.5. CT scans
4.5.1. CT scans market estimates and forecast 2018 to 2030 (USD Million)
4.6. MRI scans
4.6.1. MRI scans market estimates and forecast 2018 to 2030 (USD Million)
4.7. Ultrasound
4.7.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.8. Nuclear medicine scans
4.8.1. Nuclear medicine scans market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. UK IMAGING SERVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global UK Imaging Services End Use Market Movement Analysis
5.3. Global UK Imaging Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals estimates and forecast 2018 to 2030 (USD Million)
5.5. Diagnostic imaging centers
5.5.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key company market share analysis, 2024
6.4. Company Position Analysis
6.5. Company Categorization (Emerging Players, Innovators and Leaders
6.6. Company Profiles
6.6.1. Alliance Medical Limited
6.6.1.1. Company overview
6.6.1.2. Financial performance
6.6.1.3. Product benchmarking
6.6.1.4. Strategic initiatives
6.6.2. InHealth Group
6.6.2.1. Company overview
6.6.2.2. Financial performance
6.6.2.3. Product benchmarking
6.6.2.4. Strategic initiatives
6.6.3. Neuromed Diagnostic Imaging Centre
6.6.3.1. Company overview
6.6.3.2. Financial performance
6.6.3.3. Product benchmarking
6.6.3.4. Strategic initiatives
6.6.4. UNILABS
6.6.4.1. Company overview
6.6.4.2. Financial performance
6.6.4.3. Product benchmarking
6.6.4.4. Strategic initiatives
6.6.5. Medica Group.
6.6.5.1. Company overview
6.6.5.2. Financial performance
6.6.5.3. Product benchmarking
6.6.5.4. Strategic initiatives
6.6.6. TIC Health.
6.6.6.1. Company overview
6.6.6.2. Financial performance
6.6.6.3. Product benchmarking
6.6.6.4. Strategic initiatives
6.6.7. The Radiology Clinic.
6.6.7.1. Company overview
6.6.7.2. Financial performance
6.6.7.3. Product benchmarking
6.6.7.4. Strategic initiatives
6.6.8. affidea
6.6.8.1. Company overview
6.6.8.2. Financial performance
6.6.8.3. Product benchmarking
6.6.8.4. Strategic initiatives
6.6.9. Vista Diagnostics Limited.
6.6.9.1. Company overview
6.6.9.2. Financial performance
6.6.9.3. Product benchmarking
6.6.9.4. Strategic initiatives
6.6.10. Medical Imaging Partnership
6.6.10.1. Company overview
6.6.10.2. Financial performance
6.6.10.3. Product benchmarking
6.6.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End use outlook
2.3. Competitive Insights
CHAPTER 3. UK IMAGING SERVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic disorders
3.4.1.2. Technological advancements
3.4.1.3. Growing awareness of medical imaging
3.4.2. Market restraint analysis
3.4.2.1. High radiation exposure
3.4.2.2. Lack of resources
3.5. UK Imaging Services Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
CHAPTER 4. UK IMAGING SERVICES MARKET: MODALITY ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Global UK Imaging Services Modality Market Movement Analysis
4.3. Global UK Imaging Services Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. X-rays scans
4.4.1. X-rays scans market estimates and forecast 2018 to 2030 (USD Million)
4.5. CT scans
4.5.1. CT scans market estimates and forecast 2018 to 2030 (USD Million)
4.6. MRI scans
4.6.1. MRI scans market estimates and forecast 2018 to 2030 (USD Million)
4.7. Ultrasound
4.7.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
4.8. Nuclear medicine scans
4.8.1. Nuclear medicine scans market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. UK IMAGING SERVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Global UK Imaging Services End Use Market Movement Analysis
5.3. Global UK Imaging Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals estimates and forecast 2018 to 2030 (USD Million)
5.5. Diagnostic imaging centers
5.5.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key company market share analysis, 2024
6.4. Company Position Analysis
6.5. Company Categorization (Emerging Players, Innovators and Leaders
6.6. Company Profiles
6.6.1. Alliance Medical Limited
6.6.1.1. Company overview
6.6.1.2. Financial performance
6.6.1.3. Product benchmarking
6.6.1.4. Strategic initiatives
6.6.2. InHealth Group
6.6.2.1. Company overview
6.6.2.2. Financial performance
6.6.2.3. Product benchmarking
6.6.2.4. Strategic initiatives
6.6.3. Neuromed Diagnostic Imaging Centre
6.6.3.1. Company overview
6.6.3.2. Financial performance
6.6.3.3. Product benchmarking
6.6.3.4. Strategic initiatives
6.6.4. UNILABS
6.6.4.1. Company overview
6.6.4.2. Financial performance
6.6.4.3. Product benchmarking
6.6.4.4. Strategic initiatives
6.6.5. Medica Group.
6.6.5.1. Company overview
6.6.5.2. Financial performance
6.6.5.3. Product benchmarking
6.6.5.4. Strategic initiatives
6.6.6. TIC Health.
6.6.6.1. Company overview
6.6.6.2. Financial performance
6.6.6.3. Product benchmarking
6.6.6.4. Strategic initiatives
6.6.7. The Radiology Clinic.
6.6.7.1. Company overview
6.6.7.2. Financial performance
6.6.7.3. Product benchmarking
6.6.7.4. Strategic initiatives
6.6.8. affidea
6.6.8.1. Company overview
6.6.8.2. Financial performance
6.6.8.3. Product benchmarking
6.6.8.4. Strategic initiatives
6.6.9. Vista Diagnostics Limited.
6.6.9.1. Company overview
6.6.9.2. Financial performance
6.6.9.3. Product benchmarking
6.6.9.4. Strategic initiatives
6.6.10. Medical Imaging Partnership
6.6.10.1. Company overview
6.6.10.2. Financial performance
6.6.10.3. Product benchmarking
6.6.10.4. Strategic initiatives
